Combinational usage of next generation sequencing and qPCR for the analysis of tumor samples (Q34487574)

2 August 2017

1 reference

title

Combinational usage of next generation sequencing and qPCR for the analysis of tumor samples (English)

1 reference

2 August 2017

Robert P Loewe

1

1 reference

PubMed ID

23178393

2 August 2017

language of work or name

1 reference

21 November 2012

1 reference

2 August 2017

1 reference

2 August 2017

59

1 reference

2 August 2017

1

1 reference

2 August 2017

126-131

1 reference

Key principles and clinical applications of "next-generation" DNA sequencing

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.11.002

RNA-Seq analyses generate comprehensive transcriptomic landscape and reveal complex transcript patterns in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.11.002

Deep Sequence Analysis of Non-Small Cell Lung Cancer: Integrated Analysis of Gene Expression, Alternative Splicing, and Single Nucleotide Variations in Lung Adenocarcinomas with and without Oncogenic KRAS Mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.11.002

BRAF(V600E) mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.11.002

RRM1 expression and clinical outcome of gemcitabine-containing chemotherapy for advanced non-small-cell lung cancer: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.11.002

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.11.002

Crizotinib in ALK-positive lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.11.002

Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.11.002

Modulation of HER3 is a marker of dynamic cell signaling in ovarian cancer: implications for pertuzumab sensitivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.11.002

Denosumab: a new option in the treatment of bone metastases from urological cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.11.002

Nucleic acid quantity and quality from paraffin blocks: defining optimal fixation, processing and DNA/RNA extraction techniques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.11.002

Identification of tyrosine kinases overexpressed in head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.11.002

Titration-free massively parallel pyrosequencing using trace amounts of starting material

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.11.002

Read count approach for DNA copy number variants detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.11.002

Accurate and objective copy number profiling using real-time quantitative PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2012.11.002

10.1016/J.YMETH.2012.11.002

7 January 2021

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

23178393